ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryChâtelaineargenx Switzerland SA
argenx Switzerland SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

argenx Switzerland SA is a biopharmaceutical company that discovers, develops and commercializes antibody-based therapies for severe autoimmune diseases. Its portfolio includes the FcRn-targeting agent efgartigimod (marketed as VYVGART and VYVGART Hytrulo), a pipeline of additional antibody candidates such as empasiprubart, and ongoing clinical research.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

argenx Switzerland SA

✓ Offered
5
Immunology Innovation Program (IIP)
Co-creation in partnership with academic and clinical researchers to transform immunology insights into antibody-based medicines, from discovery through clinical development.
Commercial medicines and products
VYVGART and VYVGART Hytrulo, products approved in the United States, with dedicated information for healthcare professionals and patients.
Clinical development portfolio
Programs for efgartigimod, empasiprubart and other preclinical candidates, phase 1, proof of concept, registrational and commercial across multiple therapeutic areas.
Externally Sponsored Research (ESR)
Support for Investigator-Initiated Studies and Clinical Research Collaboration, with proposal submission, research guidance, and a dedicated point of contact.
Patient access to therapies and clinical trials
Information on clinical trials, pre-approval and post-trial access, as well as resources for patients living with rare autoimmune diseases.
Trust & reputation

ranQ Trust Score of argenx Switzerland SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

argenx Switzerland SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
argenx Switzerland SA scores 76.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
argenx Switzerland SA scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
argenx Switzerland SA scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

argenx Switzerland SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once argenx Switzerland SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

argenx Switzerland SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank argenx Switzerland SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of argenx Switzerland SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Place Casa-Bamba 1
1219 Châtelaine

At a glance

Legal form
Corporation
UID
CHE-192.432.916
Founded
2020 · 6 years
Last commercial register change
May 15, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    SS
    STALICLA SA
    Geneva
    MM
    MMV MEDICINES FOR MALARIA VENTURE
    Cointrin
    IS
    iOnctura SA
    Geneva
    RP
    Rebio Pharma Sàrl
    Geneva
    SG
    SANOFI GESTION SA
    Vernier
    TP
    Telix Pharmaceuticals (Switzerland) Sàrl
    Petit-Lancy
    RF
    ReMedys Foundation
    Geneva
    LP
    Labatec Pharma SA
    Meyrin